Navigation Links
Asymchem Announces sFDA Certification for Drug Product Manufacturing
Date:6/4/2009

TEDA TIANJIN, China, June 4 /PRNewswire/ -- Asymchem Laboratories, Inc., a leading research-based contract manufacturer of intermediates, API's and drug products to the pharmaceutical industry, is pleased to announce the issuance by the Tianjin branch of the Chinese State Food and Drug Administration (sFDA), a manufacturing certificate for drug products to our Tianjin 2 site. This qualifies Asymchem to manufacture oral solid dosage forms including tablets, capsules, and pellets.

Asymchem offers preclinical and drug product programs that include preformulation and formulation development, and clinical supply manufacturing of oral dosage forms. Housed in a 250 m2 state-of-the-art facility in Asymchem's Tianjin 2 site, Asymchem's drug product manufacturing facility is capable of producing up to kilogram scale of tablets or capsules per batch to support phase 1 and phase 2 clinical studies. Separate facility of similar scale exists for manufacture of dosage forms containing highly potent or cytotoxic compounds. Meanwhile, a much larger drug product facility for commercial manufacturing is being built and expected to be operational by 2Q 2010.

"We feel drug product capabilities to support all phases of our collaborator's research, development, and manufacturing are a logical extension of our long-standing capabilities in API development and manufacturing," states Dr. Hao Hong, CEO of Asymchem. "Our recent successful sFDA audit demonstrates that we bring the same focus on quality and regulatory compliance to our drug product programs that we have always brought to our API programs."

Dr. Xiaorong He, director of Formulation Development for Asymchem adds: "Operating to the highest technical and regulatory standards is part of the Asymchem culture, and our recent certification demonstrates our commitment to these ideals."

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14 year track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Asymchem Continues to Maintain a Good Running Posture, Despite Economic Crisis
2. Asymchem Announces Opening of High Potency API and Drug Product Facility
3. LOHAS Announces Final Program Line-up Including Speakers from Wal-Mart, Coca Cola, MINI, Facebook Causes, Saatchi & SaatchiS, Gaiam and eBay
4. Healthcare Data Services (HDS) Announces HDS Expert(SM)
5. Aesthera Announces Installation of 1000th Photopneumatic System in US
6. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
7. Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference
8. Anpath Group, Inc. Announces Selection of its Cleaner by the Toronto Transit System
9. Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
10. US Oncology, Inc. Announces $465 Million Senior Secured Notes Offering
11. DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: